Champions Oncology Inc

CSBR | Healthcare | NASDAQ
$6.50
-0.38 (-5.52%)

Key Metrics

Market Cap
$90.26M
P/E Ratio
-36.11
EPS
$-0.18
Beta
N/A
Dividend Yield
N/A
ROE
-57.99%
Current Ratio
0.98

Company Information

Industry
Biotechnology

About Champions Oncology Inc

Champions Oncology Inc is dedicated to developing and commercializing cuttingedge technological products and services designed to personalize cancer treatment and streamline the development of oncology drugs across the United States At the heart of its offerings is the Tumorgraft Technology Platform an innovative approach that facilitates individualized cancer care by implanting human tumors into immunedeficient mice Utilizing this proprietary platform the company not only delivers personalized cancer solutions directly but also provides Translational Oncology Solutions supporting pharmaceutical and biotechnology companies through their drug development lifecycle Additionally Champions Oncology offers Lumin Bioinformatics a comprehensive software platform and data tool filled with insights from research services and clinical studies accessible through annual subscriptions The company distributes its offerings through various channels including online platforms wordofmouth referrals and a dedicated sales team reaching both patients and healthcare professionals Established in 1985 Champions Oncology Inc is based in Hackensack New Jersey and was formerly known as Champions Biotechnology Inc until its name change in April 2011

Recent Earnings Surprises

Date Actual EPS Estimated EPS Surprise
2026-03-12 $-0.02 $0.09 -122.2%
2025-12-15 $0.02 $0.08 -75.0%
2025-09-15 $-0.03 $0.01 -400.0%
2025-07-23 $-0.13 $0.06 -316.7%

Financial Ratios (TTM)

Gross Margin
45.88%
Operating Margin
-3.84%
Net Margin
-3.94%
ROA
-8.02%
Price to Book
22.31
Price to Sales
1.65